Effects of the dual peroxisome proliferator–activated receptor activator aleglitazar in patients with Type 2 Diabetes mellitus or prediabetes
Erdmann, Erland, MD, Califf, Robert, MD, Gerstein, Hertzel C., MD, Malmberg, Klas, MD, Ruilope, Luis, MD, Schwartz, Gregory G., MD, Wedel, Hans, MD, Volz, Dietmar, MD, Ditmarsch, Marc, MD, Svensson, Anders, MD, Bengus, Monica, MD
Published in The American heart journal (01.07.2015)
Published in The American heart journal (01.07.2015)
Get full text
Journal Article